UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characteristics, costs, and outcomes associated with central-line–associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals

Infection control and hospital epidemiology, 2023-12, Vol.44 (12), p.1920-1926

2023

Volltextzugriff (PDF)

Outcomes of inadequate empiric therapy and timing of newer antibacterial therapy in hospitalized adults with culture-positive Enterobacterales and Pseudomonas aeruginosa: a multicenter analysis

BMC infectious diseases, 2024-08, Vol.24 (1), p.810-13, Article 810

2024

Volltextzugriff (PDF)

Clinical and economic burden of invasive pneumococcal disease and noninvasive all-cause pneumonia in hospitalized US adults: A multicenter analysis from 2015 to 2020

International journal of infectious diseases, 2024-06, Vol.143, p.107023-107023, Article 107023

2024

Volltextzugriff (PDF)

Treated, hospital-onset Clostridiodes difficile infection: An evaluation of predictors and feasibility of benchmarking comparing 2 risk-adjusted models among 265 hospitals

Infection control and hospital epidemiology, 2024-01, Vol.45 (1), p.48-56

2024

Volltextzugriff (PDF)

Regional Differences in Antibiotic-resistant Enterobacterales Urine Isolates in the United States: 2018-2020

International journal of infectious diseases, 2022-06, Vol.119, p.142-145

2022

Volltextzugriff (PDF)

Hospital-level high-risk antibiotic use in relation to hospital-associated Clostridioides difficile infections: Retrospective analysis of 2016-2017 data from US hospitals

Infection control and hospital epidemiology, 2019-11, Vol.40 (11), p.1229-1235

2019

Volltextzugriff (PDF)

Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation

BMC infectious diseases, 2022-11, Vol.22 (1), p.1-841, Article 841

2022

Volltextzugriff (PDF)

Older patient age and prior antimicrobial use strongly predict antimicrobial resistance in Escherichia coli isolates recovered from urinary tract infections among female outpatients

PloS one, 2023-05, Vol.18 (5), p.e0285427-e0285427

2023

Volltextzugriff (PDF)

A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020

BMC infectious diseases, 2022-02, Vol.22 (1), p.194-12, Article 194

2022

Volltextzugriff (PDF)

A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19

BMC infectious diseases, 2021-02, Vol.21 (1), p.227-227, Article 227

2021

Volltextzugriff (PDF)

Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021)

BMC infectious diseases, 2023-07, Vol.23 (1), p.490-490, Article 490

2023

Volltextzugriff (PDF)

A multicenter evaluation of antibacterial use in hospitalized patients through the SARS-Cov-2 pandemic waves

BMC infectious diseases, 2023-02, Vol.23 (1), p.117-117, Article 117

2023

Volltextzugriff (PDF)

Real-world in vitro activity of newer antibiotics against Enterobacterales and Pseudomonas aeruginosa , including carbapenem-non-susceptible and multidrug-resistant isolates: a multicenter analysis

Microbiology spectrum, 2023-12, Vol.11 (6), p.e0312923-e0312923

2023

Volltextzugriff (PDF)

Testing for Coccidioidomycosis among Community-Acquired Pneumonia Patients, Southern California, USA

Emerging infectious diseases, 2018-04, Vol.24 (4), p.779-781

2018

Volltextzugriff (PDF)

A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints

Microbiology spectrum, 2022-06, Vol.10 (3), p.e0115822-e0115822

2022

Volltextzugriff (PDF)

Trends and outcomes in community-onset and hospital-onset Staphylococcus bacteremia among hospitals in the United States from 2015 to 2020

Antimicrobial stewardship & healthcare epidemiology : ASHE, 2024, Vol.4 (1), p.e136

2024

Volltextzugriff (PDF)

Hospital-onset bacteremia: clinical and regulatory ramifications

Future microbiology, 2023-11, Vol.18 (16), p.1133-1136

2023

Volltextzugriff (PDF)

A multicenter analysis of inpatient antibiotic use during the 2015-2019 influenza seasons in the United States: Untapped opportunities for antimicrobial stewardship

Antimicrobial stewardship & healthcare epidemiology : ASHE, 2022, Vol.2 (1), p.e140-e140, Article e140

2022

Volltextzugriff (PDF)

Antibiotic Stewardship in Small Hospitals: Barriers and Potential Solutions

Clinical infectious diseases, 2017-08, Vol.65 (4), p.691-696

2017

Volltextzugriff (PDF)

Association Between Social Vulnerability and Streptococcus pneumoniae Antimicrobial Resistance in US Adults

Clinical infectious diseases, 2024-08, Vol.79 (2), p.305-311

2024

Volltextzugriff (PDF)

Incidence of Polymerase Chain Reaction–Diagnosed Clostridium difficile in a Large High-Risk Cohort, 2011-2012

Mayo Clinic proceedings, 2014-09, Vol.89 (9), p.1229-1238

2014

Volltextzugriff (PDF)

Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals

Infection control and hospital epidemiology, 2022-10, Vol.43 (10), p.1317-1325

2022

Volltextzugriff (PDF)

Relationships between creatinine increase and mortality rates in patients given vancomycin in 76 hospitals: The increasing role of infectious disease pharmacists

American journal of health-system pharmacy, 2021-12, Vol.78 (23), p.2116-2125

2021

Volltextzugriff (PDF)

The impact of infections on reimbursement in 92 US hospitals, 2015-2018

American journal of infection control, 2021-10, Vol.49 (10), p.1275-1280

2021

Volltextzugriff (PDF)

Benchmarking Inpatient Antimicrobial Use: A Comparison of Risk-Adjusted Observed-to-Expected Ratios

Clinical infectious diseases, 2018-11, Vol.67 (11), p.1677-1685

2018

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(36)
Infectious Diseases
(26)
Humans
(20)
Hospitals
(13)
Microbiology
(13)
Female
(11)
Adult
(10)
Immunology
(10)
Male
(10)
Aged
(9)
Antibiotics
(9)
Retrospective Studies
(9)
Risk Factors
(9)
Antibiotic Resistance
(8)
Hospitalization
(8)
Middle Aged
(8)
Mortality
(8)
Anti-Bacterial Agents - Therapeutic Use
(7)
Care And Treatment
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Characteristics, costs, and outcomes associated with central-line–associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals

Outcomes of inadequate empiric therapy and timing of newer antibacterial therapy in hospitalized adults with culture-positive Enterobacterales and Pseudomonas aeruginosa: a multicenter analysis

Clinical and economic burden of invasive pneumococcal disease and noninvasive all-cause pneumonia in hospitalized US adults: A multicenter analysis from 2015 to 2020

Treated, hospital-onset Clostridiodes difficile infection: An evaluation of predictors and feasibility of benchmarking comparing 2 risk-adjusted models among 265 hospitals

Regional Differences in Antibiotic-resistant Enterobacterales Urine Isolates in the United States: 2018-2020

Hospital-level high-risk antibiotic use in relation to hospital-associated Clostridioides difficile infections: Retrospective analysis of 2016-2017 data from US hospitals

Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation

Older patient age and prior antimicrobial use strongly predict antimicrobial resistance in Escherichia coli isolates recovered from urinary tract infections among female outpatients

A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020

A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19

Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021)

A multicenter evaluation of antibacterial use in hospitalized patients through the SARS-Cov-2 pandemic waves

Real-world in vitro activity of newer antibiotics against Enterobacterales and Pseudomonas aeruginosa , including carbapenem-non-susceptible and multidrug-resistant isolates: a multicenter analysis

Testing for Coccidioidomycosis among Community-Acquired Pneumonia Patients, Southern California, USA

A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints

Trends and outcomes in community-onset and hospital-onset Staphylococcus bacteremia among hospitals in the United States from 2015 to 2020

Hospital-onset bacteremia: clinical and regulatory ramifications

A multicenter analysis of inpatient antibiotic use during the 2015-2019 influenza seasons in the United States: Untapped opportunities for antimicrobial stewardship

Antibiotic Stewardship in Small Hospitals: Barriers and Potential Solutions

Association Between Social Vulnerability and Streptococcus pneumoniae Antimicrobial Resistance in US Adults

Incidence of Polymerase Chain Reaction–Diagnosed Clostridium difficile in a Large High-Risk Cohort, 2011-2012

Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals

Relationships between creatinine increase and mortality rates in patients given vancomycin in 76 hospitals: The increasing role of infectious disease pharmacists

The impact of infections on reimbursement in 92 US hospitals, 2015-2018

Benchmarking Inpatient Antimicrobial Use: A Comparison of Risk-Adjusted Observed-to-Expected Ratios

Suchergebnisse filtern